ImmuMap is proud to enter into a master service agreement with world-leading provider of rodent models
ImmuMap Services is proud to announce that we have entered a master service agreement with Taconic Biosciences for the period July 2020 to July 2022 to perform multicolor state-of-the-art flow cytometry quality control (QC) services. Initially, as a first work order under the MSA we will perform regular testing of Taconic humanized immune system (huNOG) mice.
Taconic Biosciences generates and distributes genetically engineered mouse and rat models for its clients in the drug development space using both proprietary technologies and technology licenses granted by multiple licensors. Please visit https://www.taconic.com/mouse-model/hunog for more details about the huNOG mice, which permit assessment of human immune response in a mouse model.
At ImmuMap we are thrilled to enter this strategic partnership, and we are looking forward to applying our knowledge and expertise in multicolor flow cytometry for ensuring high quality and reliable QC testing. By thus enabling Taconic Biosciences and its clients to reap the reward of the huNOG mice model, we aim to speed up development of new immunological medicines with patient benefit.
Do not hesitate to reach out to either ImmuMap or Taconic for further information about our services.
ImmuMap Services Taconic Biosciences
Thomas M. Frøsig, PhD Kelly Owen Grover, MBA
CEO Director of Marketing Communications
C: +45 61 78 18 82 C: +1 315 723 4993